Cortés-Hernández Dora E, Lundelin Krista J, Picazzo-Palencia Esteban, de la Cruz Juan J, Sánchez José J, Banegas José R
Department of Public Health and Preventive Medicine, School of Medicine and Center for Research and Development on Health Science, Universidad Autónoma de Nuevo Leon, 64460 Monterrey, NL, Mexico ; Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPAZ, CIBER in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPAZ, CIBER in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Int J Hypertens. 2014;2014:427684. doi: 10.1155/2014/427684. Epub 2014 Feb 10.
This study shows that in Mexico, a country at an advanced stage in the epidemiologic transition, with the national burden of disease dominated by noncommunicable diseases, elevated blood pressure is a major clinical and public health problem. 31.7% of the Mexican individuals aged 50 and over had systolic hypertension, and 47.3% were at systolic prehypertensive levels. Also, approximately half of all cardiovascular deaths that occurred annually in the population of Mexico aged ≥50 years are attributable to above optimal levels of systolic blood pressure. We think these estimates may help order health priorities in Mexico (and other middle-income countries) at a time when the costs of medical care take a considerable share of the gross national product in most countries.
这项研究表明,在墨西哥这个处于流行病学转变高级阶段、非传染性疾病占国家疾病负担主导地位的国家,血压升高是一个主要的临床和公共卫生问题。50岁及以上的墨西哥人中有31.7%患有收缩期高血压,47.3%处于收缩期高血压前期水平。此外,在墨西哥年龄≥50岁的人群中,每年发生的所有心血管死亡病例中约有一半可归因于收缩压高于最佳水平。我们认为,在大多数国家医疗保健成本占国民生产总值相当大比例的这个时期,这些估计数字可能有助于确定墨西哥(以及其他中等收入国家)的卫生工作重点。